Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVJF) Return on Assets (2016 - 2025)

Historic Return on Assets for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to 0.04%.

  • Teva Pharmaceutical Industries' Return on Assets rose 700.0% to 0.04% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.04%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.04% for FY2025, which is 800.0% up from last year.
  • Teva Pharmaceutical Industries' Return on Assets amounted to 0.04% in Q4 2025, which was up 700.0% from 0.02% recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Return on Assets registered a high of 0.04% during Q4 2025, and its lowest value of 0.08% during Q1 2021.
  • For the 5-year period, Teva Pharmaceutical Industries' Return on Assets averaged around 0.03%, with its median value being 0.04% (2025).
  • Data for Teva Pharmaceutical Industries' Return on Assets shows a peak YoY increase of 1000bps (in 2021) and a maximum YoY decrease of -800bps (in 2021) over the last 5 years.
  • Teva Pharmaceutical Industries' Return on Assets (Quarter) stood at 0.01% in 2021, then tumbled by -710bps to 0.06% in 2022, then fell by -18bps to 0.07% in 2023, then surged by 62bps to 0.03% in 2024, then surged by 259bps to 0.04% in 2025.
  • Its last three reported values are 0.04% in Q4 2025, 0.02% for Q3 2025, and 0.0% during Q2 2025.